share_log

Myovant Sciences Q3 Sales $100.20M Miss $102.36M Estimate

Benzinga Real-time News ·  Jan 26, 2023 16:23

Myovant Sciences (NYSE:MYOV) reported quarterly sales of $100.20 million which missed the analyst consensus estimate of $102.36 million by 2.11 percent. This is a 7.17K percent increase over sales of $1.38 million the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment